Meet Communications Biology authors from Japan

Meet our authors from RIKEN Bioresource Research Center, Meijo University, and the National Institute of Advanced Industrial Science and Technology in Japan to learn about their fascinating invention for improving pluripotent stem cell culturing.
Like

Share this post

Choose a social network to share with, or copy the URL to share elsewhere

This is a representation of how your post may appear on social media. The actual post will vary between social networks

In this video, three authors (Drs. Yohei Hayashi, Kazuhiro Hotta, and Kimio Sumaru) talk about how they came to develop an automatic cell processing system that helps researchers maintain the culture of human induced pluripotent stem cells by selectively eliminating spontaneously differentiated cells. This story illustrates the power of interdisciplinary collaboration that encompasses stem cell research, materials engineering, machine learning, and computer vision. These researchers also tell us about how they hope to bring this technology to the next level. This work has recently been published in Communications Biology.

Please sign in or register for FREE

If you are a registered user on Research Communities by Springer Nature, please sign in

Follow the Topic

Biotechnology
Life Sciences > Biological Sciences > Biotechnology

Related Collections

With Collections, you can get published faster and increase your visibility.

From RNA Detection to Molecular Mechanisms

With this cross-journal Collection, the editors at Nature Communications, Communications Biology and Scientific Reports invite manuscripts that highlight innovative methods for visualising and detecting RNA molecules and modifications in vivo, and studies that use these tools to uncover RNA-based regulatory mechanisms.

Publishing Model: Open Access

Deadline: May 05, 2026

Advances in neurodegenerative diseases

This Collection aims to bring together research from various domains related to neurodegenerative conditions, encompassing novel insights into disease pathophysiology, diagnostics, therapeutic developments, and care strategies. We welcome the submission of all papers relevant to advances in neurodegenerative disease.

Publishing Model: Hybrid

Deadline: Jun 30, 2026